Levels of circulating biomarkers at rest and after exercise in coronary artery disease patients

Physiological Research

Volumn 59, Issue 3, 2010, Pages 385-392

  Danzig, V ^a   Mikova B ^b   Kuchynka, P ^a   Benakova H ^a   Zima, T ^a   Kittnar, O ^c   Skrha J ^a   Linhart, A ^a   Kalousova M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Railway Hospital   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Coronary artery disease; Inflammation; Metalloproteinases; Natriuretic peptides; Oxidative stress

Indexed keywords

AUTACOID; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BICYCLE; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMAN; MALE; MIDDLE AGED; OXIDATIVE STRESS; PATHOPHYSIOLOGY;

ADULT; AGED; BICYCLING; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 77956218629     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. ASCHERMANN M: Ischemic heart disease (in Czech). In: Kardiologie. Galén, Praha, 2004, pp 344-348.
2. BAYES-GENIS A, CONOVER CA, OVERGAARD MT, BAILEY KR, CHRISTINSEN M, HOLME DR Jr, VIRMANI R, OXVIG C, SCHWARZ RS: Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 345: 1022-1029, 2001.
3. BEAUDEUX JL, GIRAL P, BRUCKERT E, FOGLIETTI MJ, CHAPMAN MJ: Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives. Clin Chem Lab Med 42: 121-131, 2004.
4. BRIXIUS K, SCHOENBERGER S, LADAGE D, KNIGGE H, FALKOWSKI G, HELLMICH M, GRAF C, LATSCH J, MONTIE GL, PREDE GL, BLOCH W: Long-term endurance exercise decreases the antiangiogenic endostatin signaling in adipose men aged between 50-60 years. Br J Sports Med 42: 126-129, 2008.
5. BUCCIARELLI LG, WENDT T, RONG L, LALLA E, HOFMANN MA, GOOVA MT, TAGUCHI A, YAN SF, YAN SD, STERN DM, SCHMIDT AM: RAGE is a multiligand receptor of the immonoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol Life Sci 59: 1117-1128, 2002.
6. BÜTTNER P, MOSIG S, LECHTERMANN A, FUNKE H, MOOREN FC: Exercise affects the gene expression profile of human white blood cells. J Appl Physiol 102: 26-36, 2007.
7. CARMELI E, MOAS M, LENNON S, POWERS SK: High intensity exercise increases expression of matrix metalloproteinases in fast skeletal muscle fibres. Exp Physiol 90: 613-619, 2005.
8. CÍFKOVÁ R, ŠKODOVÁ Z: Changes of risk factors in the population and a decrease of cardiovascular mortality (in Czech). JACC-CZ 4: 77-80, 2002.
9. FALCONE C, EMANUELE E, D'ANGELO A, BUZZI MP, BELVITO C, CUCCIA M, GEROLDI D: Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler Tromb Vasc Biol 25: 879-882, 2005.
10. FOOTE RS, PEARLMAN JD, SIEGEL AH, YEO KT: Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 44: 1980-1987, 2004.
11. GELUK CA, POST WJ, HILLEGE HL, TIO RA, TIJSSEN JG, VAN DIJK RB, DIJK WA, BAKKER SJ, DE JONG PE, VAN GILST WH, ZIJLSTRA F: C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: data from the prospective PREVEND cohort. Atherosclerosis 196: 372-382, 2008.
12. GELUK CA, TIO RA, TIJSSEN JG, VAN DIJK RB, DIJK WA, HILLEGE HL, DE JONG PE, VAN GILST WH, ZIJLSTRA F: Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort. Neth Heart J 15: 133-141, 2007.
13. GEROLDI D, FALCONE C, EMANUELE E, D'ANGELO A, CALCAGNINO M, BUZZI MP, SCIOLI GA, FOGARI R: Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. Hypertension 23: 1725-1729, 2005.
14. HESS OM, MC KENNA W, SCHULTHEISS HP: Myocardial disease. In: The ESC Textbook of Cardiovascular Medicine. CAMM AJ, LÜSCHER TF, SERRYUS PW (eds), Blackwell Publishing, Oxford, 2006, pp 453-515.
15. KALOUSOVÁ M, SULKOVÁ S, FIALOVÁ L, SOUKUPOVÁ J, MALBOHAN IM, ŠPAČEK P, BRAUN M, MIKULÍKOVÁ L, FORTOVÁ M, HOŘEJŠÍ M, TESAŘ V, ZIMA T: Glycoxidation and inflammation in chronic haemodialysis patients. Nephrol Dial Transplant 18: 2577-2581, 2003.
16. KALOUSOVÁ M, JÁCHYMOVÁ M, MESTEK O, HODKOVÁ M, KAZDEROVÁ M, TESAR V, ZIMA T: Receptor for advanced glycation end products-soluble form and gene polymophism in chronic haemodialysis patients. Nephrol Dial Transplant 22: 2020-2026, 2007.
17. KANEDA H, TAGUCHI J, OGASAWARA K, AIZAWA T, OHNO M: Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 162: 221-225, 2002.
18. 2 max in asymptomatic men. J Appl Physiol 102: 1374-1379, 2007.
19. MAISEL AS, KOON J, KRISHNASWAMY P, KAZENEGRA R, CLOPTON P, GARDETTO N, MORRISEY R, GARCIA A, CHIU A, DE MARIA A: Utility of B-natriuretic peptide as a rapid point of care test for screeining patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 141: 367-374, 2001.
20. MCQUIBBAN GA, GONG JH, TAM EM, MCCULLOCH CA, CLARK-LEWIS I, OVERALL CM: Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289: 1202-1206, 2000.
21. NAKAMURA K, YAMAGISHI S, ADACHI H, KURITA-NAKAMURA Y, MATSUI T, YOSHIDA T, SATO A, IMAIZUMI T: Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjcts with coronary artery disease. Diabetes Metab Res Rev 23: 368-371, 2007.
22. NEUFELD G, COHEN T, GENGRINOVITCH S, POLTORAK Z: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22, 1999.
23. PARKS WC, MECHAM RP: Matrix Metaloproteinasis. Academic Press, San Diego, 1998.
24. PIALOUX V, MOUNIER R, PONSOT E, ROCK E, MAZUR A, DUFOUR S, RICHARD R, RICHALET JP, COUDERT J, FELLMANN N: Effects of exercise and training in hypoxia on antioxidant/pro-oxidant balance. Eur J Clin Nutr 60: 1345-1354, 2006.
25. POHOST GM, O' ROURKE RA, BERMAN DS: Imaging in Cardiovascular Disease. Lippincott Williams and Wilkins, Philadelphia, 2000.
26. RACEK J, RACKOVÁ M: Less common risk factors of atherogenesis - homocysteine, lipoprotein (a) and C-reactive protein (in Czech). Cas Lek Cesk 141: 605-609, 2002.
27. RIDKER PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107: 363-369, 2003.
28. SHIMIZU Y, SHAW S, GRABER N, GOPAL TV, HORGAN KJ, VAN SEVENTER GA, NEWMAN W: Activation- independent binding of human memory T cells to adhesion molecule ELAM-I. Nature 349: 799-802, 1991.
29. SIGNORELLI SS, MAZZARINO MC, DI PINO L, MALAPONTE G, PORTO C, PENNISI G, MARCHESE G, COSTA MP, DIGRANDI D, CELOTTA G, VIRGILIO V: High circulating levels of cytokines (IL-6 and TNF α), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test. Vasc Med 8:15-19, 2003.
30. STERN S: State of art in stress testing and ischemia monitoring. Card Electrophysiol Rev 6: 204-208, 2002.
31. SUHR F, BRIXIUS K, DE MARÉES M, BÖLCK B, KLEINÖDER H, ACHTZEHN S, BLOCH W, MESTER J: Effects of short-term vibration and hypoxia during high-intensity cycling exercise on circulating levels of angiogenic regulators in humans. J Appl Physiol 103: 464-483, 2007.
32. SUNG KC, SUH JY, KIM BS, KANG JH, KIM H, LEE MH, PARK JR, KIM SW: High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens 16: 429-433, 2003.
33. VANZETTO G, JACON P, CALIZZANO A, NEUDER Y, FAURE P, FAGRET D, MACHECOURT J: N-terminal pro-brain natriuretic peptide predicts myocardial ischemia and is related to postischemic left-ventricular dysfunction in patients with stable coronary artery disease. J Nucl Cardiol 14: 835-842, 2007.
34. WIN HK, CHANG SM, RAIZNER M, SHAH G, AL BASKY F, DESAI U, PLANA JC, MAHMARIAN JJ, QUINONES MA, ZOGHBI WA: Percent change in B-type natriuretic peptide levels during treadmill exercise as a screening test for exercise-induced myocardial ischemia Am Heart J 4: 695-700, 2005.
35. WITKO-SARSAT V, FRIEDLANDER M, CAPEILLÈRE-BLANDIN C, NGUYEN-KHOA T, NGUYEN AT, ZINGRAFF J, JUNGERS P, DESCAMPS-LATSCHA B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49: 1304-1313, 1996.
36. WU TC, LEU HB, LIN WT, LIN CP, LIN SJ, CHEN JW: Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease. Eur J Clin Invest 35: 537-545, 2005.